56 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

605116

Aurisco PharmaceuticalLtd
CN¥24.628.7%-4.9%CN¥9.5bCN¥31.00PE38.9xE30.2%0.6%

301096

Hangzhou Bio-Sincerity Pharma-TechLtd
CN¥68.70-6.5%5.4%CN¥7.5bCN¥83.82PE26.1xE29.7%1.2%

1952

Everest Medicines
HK$23.501.5%63.4%HK$7.6bHK$28.05PS55.2xE80.2%n/a

AMYT

Amryt Pharma
US$14.700.7%86.5%US$940.7mUS$20.75PS3.9xE53.9%n/a

688621

Beijing Sun-Novo Pharmaceutical Research
CN¥57.88-1.0%-16.4%CN¥6.4bn/aPE33.4xE37.2%0.7%

300725

PharmaBlock Sciences (Nanjing)
CN¥31.724.0%-43.5%CN¥6.1bCN¥52.00PE33.5xE42.0%0.3%

603229

Zhejiang Ausun Pharmaceutical
CN¥10.406.9%-36.9%CN¥6.0bn/aPE21.7xE27.3%0.8%

BLUEJET

Blue Jet Healthcare
₹391.75-0.2%n/a₹66.2b₹430.00PE38.9xE25.9%n/a

6589

EirGenix
NT$79.00-2.0%-24.0%NT$24.2bNT$132.50PS23.7xE143.6%n/a

FYB

Formycon
€39.10-2.7%-43.7%€690.5m€95.25PS10.1xE37.6%n/a

688046

GemPharmatech
CN¥12.105.9%-47.2%CN¥4.9bCN¥21.13PE31.2xE31.2%0.3%

688356

Jenkem Technology
CN¥78.40-1.1%-39.1%CN¥4.7bCN¥106.00PE38.7xE28.0%1.2%

ORCHPHARMA

Orchid Pharma
₹1,092.402.0%176.3%₹54.0b₹1,130.00PE44.5xE41.2%n/a

688687

Beijing Kawin Technology Share-Holding
CN¥28.3014.9%-1.4%CN¥4.6bCN¥48.72PE40.3xE29.8%0.9%

688131

Shanghai Haoyuan Chemexpress
CN¥31.285.0%-58.8%CN¥4.5bn/aPE38.8xE48.8%0.9%

688202

Shanghai Medicilon
CN¥32.69-2.7%-69.9%CN¥4.4bn/aPS3.2xE87.6%0.9%

301393

Suzhou Highfine Biotech
CN¥41.748.6%n/aCN¥4.2bn/aPE45.5xE43.1%0.6%

300636

Jiangxi Synergy Pharmaceutical
CN¥10.3912.3%-24.2%CN¥4.2bCN¥9.30PE41.1xE29.2%0.4%

AMIORG

Ami Organics
₹1,222.251.4%14.0%₹44.9b₹1,298.00PE108.1xE50.3%0.2%

PHM

Pharma Mar
€28.427.2%-30.7%€501.3m€49.20PE440.9xE47.1%2.3%

VLA

Valneva
€3.59-0.3%-17.0%€498.0m€8.95PS3.2xE50.9%n/a

300639

Guangdong Hybribio BiotechLtd
CN¥6.06-3.0%-36.3%CN¥3.7bn/aPE27.6xE42.5%3.8%

301230

PharmaResources (Shanghai)
CN¥32.472.3%-20.2%CN¥3.4bn/aPE92.9xE62.3%1.1%

TBPH

Theravance Biopharma
US$9.46-2.4%-15.5%US$459.4mUS$15.40PS8xE61.4%n/a
Page 2 of 3
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.